Duchenne Muscular Dystrophy May Be Helped With Cardiac Stem Cells
Study shows cardiac stem cells used to treat heart attacks may also help children with muscular dystrophy. Dr. Bruce Hensel reports for the NBC4 News at 5 on...
By: CoalitionDuchenne
Go here to read the rest:
Duchenne Muscular Dystrophy May Be Helped With Cardiac Stem Cells - Video
Anti-Aging Treatment
A treatment from Nature Pure targeted to treat anti-aging with their Black Currant, high in vitamin-C and Reservatol, and their Stem Cells and Soy Isoflavones. Nature Pure uses Certified Organic...
By: Amra Lear
Read more here:
Anti-Aging Treatment - Video
Uncle Dolan - Stem Cells
Gooby pls.
By: Hansi Burger
Continue reading here:
Uncle Dolan - Stem Cells - Video
How Stem Cells Heal Chronic Diseases
Okyanos Chief Science Officer Dr. Leslie Miller explains the definition of a stem cell as well as the function of adult stem cell therapy in mobilizing the b...
By: Okyanos
See the original post:
How Stem Cells Heal Chronic Diseases - Video
Nutech Mediworld - Pioneering human embryonic stem cell therapy
An audio visual that features patients suffering from conditions considered incurable or terminal. And how they experienced significant improvement with human embryonic stem cell therapy at...
By: Resonance Consulting
Excerpt from:
Nutech Mediworld - Pioneering human embryonic stem cell therapy - Video
Stem Cell Therapy | Recent Strides Quell Stem Cell Debate
Ethical concerns for stem cells for arthritis could be mute...maybe. Reports show that adult stem cells (Autologous) have been shown in recent studies to have significant effects on osteoarthritis...
By: Nathan Wei
Read the original here:
Stem Cell Therapy | Recent Strides Quell Stem Cell Debate - Video
Stem cell therapy may have helped patients with a form of multiple sclerosis, according to a preliminary study.
Patients with relapsing-remitting multiple sclerosis showed signs of improvement after being treated with their own, or autologous "nonmyeloablative hematopoietic stem cells," a class of blood-forming stem cells, the study found. It was published Tuesday in the Journal of the American Medical Association.
Half, or 41 patients, tested two years after treatment experienced significant improvement on the Expanded Disability Status Scale, a measure of disability. And of patients tested at 4 years, 23, or 64 percent, showed significant improvement. Four-year relapse-free survival was 80 percent and progression-free survival was 87 percent.
"To our knowledge, this is the first report of significant and sustained improvement in the EDSS score following any treatment for MS," stated the study. It was led by Dr. Richard K. Burt of Northwestern University in Chicago.
However, only limited conclusions can be drawn from the uncontrolled study, according to scientists who examined the results. While the therapy was associated with improvement, the stem cell transplant may not have been key. A conditioning regimen that partially depleted the stem cells before transplantation may have been responsible, said Dr. Stephen L. Hauser in a JAMA article accompanying the study.
"According to Carl Sagan, 'extraordinary claims require extraordinary evidence,' a standard that is not always met in this report, and not claimed by the authors. Even though the authors appropriately acknowledge many of the limitations associated with their case series, their statement that 'to our knowledge, this is the first report of significant and sustained improvement in the EDSS score following any treatment for MS' could be challenged," Hauser wrote.
Jeanne Loring, a stem cell researcher who studies multiple sclerosis and other neurodegenerative diseases, agreed that the results are far from conclusive.
"Multiple sclerosis is an autoimmune disease, meaning that the patients' own immune cells attack their own nervous systems," Loring said by email after examining the study. "The authors of the JAMA article treated MS patients with their own blood stem cells in the hope that these cells would replace some of the self-destructive immune cells."
However, the uneven course of MS makes it hard to draw conclusions, wrote Loring, who heads the Center for Regenerative Medicine at The Scripps Research Institute in La Jolla.
"Most patients with MS have attacks, followed by recovery, followed by another attack. In a few of these patients, the blood stem cell treatment seemed to extend their time between attacks. It's important to understand that other treatments, including drugs, have shown similar modest improvements, so it's too soon to celebrate a stem cell therapy."
See the article here:
MS patients given stem cells improve
A Custom Home for Stem Cells
Leonard Zon and colleagues describe how stem cells induce remodeling of the perivascular niche. Read the article: Owen J. Tamplin, Ellen M. Durand, Logan A. Carr, Sarah J. Childs, Elliott...
By: cellvideoabstracts
See the original post:
A Custom Home for Stem Cells - Video
Andrew #39;s Autism two day After a Stem Cell Treatment
Autism Andrew Stem Cell Treatment part 3 After Treatment-- The improvements two day after Stem Cell Treatment for Autism.
By: World Stem Cells LLC
See the article here:
Andrew's Autism two day After a Stem Cell Treatment - Video
Help from infertility....Stem cells...
By: Nastya Shalash
Shin splints/muscle atrophy three months after stem cell therapy by Harry Adelson, N.D.
Angela is a life-long triathlete. Ten years ago she developed severe shin splints in her left leg that resulted in atrophy of her lower leg muscles. Here, sh...
By: Harry Adelson, N.D.
See more here:
Shin splints/muscle atrophy three months after stem cell therapy by Harry Adelson, N.D. - Video
Overview of Stem Cell Therapy at New Jersey Pain Management Clinics
http://nj-pain.com/treatments/stem-cell-procedure/ Stem Cell Therapy falls under regenerative medicine, and it is now a reality in musculoskeletal medicine. This includes stem cells being...
By: New Jersey Pain Network
See original here:
Overview of Stem Cell Therapy at New Jersey Pain Management Clinics - Video
Dr Sherif Stem cell therapy on OA
lecture powerpoint.
By: Medical Center
Go here to see the original:
Dr Sherif Stem cell therapy on OA - Video
A Winnipeg-based company that has touted its ability to improve the lives of Multiple Sclerosis patients through stem cell therapy is now under the microscope after allegations of fraud from a client.
The CEO of Regenetek Research Inc. has been collecting thousands of dollars from Canadian patients looking for help. Some of the patients are now questioning the research and credentials of the man they know as Dr. Doug.
One of them is Lee Chuckry, 47. He has been living with MS for nearly two decades.
MS just keeps progressing, thats what it does. Hopefully I could stop it. That was my ultimate goal, Chuckry said in an interview with CTV News.
His efforts led him to Regenetek, and its CEO: Doug Broeska.
In testimonials, MS patients attributed miraculous medical improvement to experimental stem cell therapy. For $35,000, Regenetek patients were flown to India for the procedure.
Chuckry was one of the participants. But when he returned home, he says his symptoms worsened.
When he started digging deeper, he said, he found the doctor hed put his faith in wasnt what he claimed to be.
Im going to call Doug a con artist, Chuckry said. You are preying on people who are desperate. They are looking for hope of any sort.
Chuckry and at least one other patient have gone to the RCMP. They allege Broeska, who claims to hold a PhD and a Bachelor of Science, is a fraud who is operating as a medical researcher without proper credentials.
Original post:
Winnipeg company offering stem cell therapy is fraudulent, MS sufferer alleges
[SPEED] Embryonic Stem Cells
Thanks for watching! Hope it helped somebody! If you would like more videos on a certain topic, let me know in the comments below. I do not own these videos. I have simply sped them up for...
By: Speed Science
Read more:
[SPEED] Embryonic Stem Cells - Video
The birth and engraftment of a blood stem cell | Boston Children #39;s Hospital
When a patient receives a bone marrow transplant, the transplanted blood stem cells find their home, begin dividing and establish themselves in the body much like natural blood stem cells do....
By: Boston Children #39;s Hospital
Read the original post:
The birth and engraftment of a blood stem cell | Boston Children's Hospital - Video
How Can Stem Cell Therapy Help PRP (Platelet Rich Plasma) - Next Generation Stem Cell
http://www.nextgenerationstemcell.com Stem Cell Therapy Stem Cell Research.
By: Jasen Kobobel
See the article here:
How Can Stem Cell Therapy Help PRP (Platelet Rich Plasma) - Next Generation Stem Cell - Video
Cancer stem cells and successful and potential treatments
Robert Rees answers questions on cancer stem cells and successful and potential treatments, including antibody therapy and vaccine based immunotherapy. http:...
By: Oxford Academic (Oxford University Press)
More here:
Cancer stem cells and successful and potential treatments - Video
Live100 Hospitals - Stem Cell Therapy
"We wanted to focus on stem cell after seeing the advantages since the cells were available in the body and they were really doing wonderful research across the world which was really promising...
By: Live100 Hospitals
Read this article:
Live100 Hospitals - Stem Cell Therapy - Video
Researchers at the Stanford University School of Medicine have discovered the stem cell in mice that gives rise to bone, cartilage and a key part of bone marrow called the stroma.
In addition, the researchers have charted the chemical signals that can create skeletal stem cells and steer their development into each of these specific tissues. The discovery sets the stage for a wide range of potential therapies for skeletal disorders such as bone fractures, brittle bones, osteosarcoma or damaged cartilage.
A paper describing the findings will be published Jan. 15 in Cell.
"Millions of times a year, orthopedic surgeons see torn cartilage in a joint and have to take it out because cartilage doesn't heal well, but that lack of cartilage predisposes the patient to arthritis down the road," said Michael Longaker, MD, a professor of plastic and reconstructive surgery at Stanford and a senior author of the paper. "This research raises the possibility that we can create new skeletal stem cells from patients' own tissues and use them to grow new cartilage." Longaker is also co-director of the Stanford Institute for Stem Cell Biology and Regenerative Medicine.
An intensive search
The researchers started by focusing on groups of cells that divide rapidly at the ends of mouse bones, and then showed that these collections of cells could form all parts of bone: the bone itself, cartilage and the stroma -- the spongy tissue at the center of bones that helps hematopoietic stem cells turn into blood and immune cells. Through extensive effort, they then identified a single type of cell that could, by itself, form all these elements of the skeleton.
The scientists then went much further, mapping the developmental tree of skeletal stem cells to track exactly how they changed into intermediate progenitor cells and eventually each type of skeletal tissue.
"Mapping the tree led to an in-depth understanding of all the genetic switches that have to be flipped in order to give rise to more specific progenitors and eventually highly specialized cells," said postdoctoral scholar Charles Chan, PhD, who shares lead authorship of the paper with postdoctoral scholar David Lo, MD, graduate student James Chen and research assistant Elly Eun Young Seo. With that information, the researchers were able to find factors that, when provided in the right amount and at the right time, would steer the development of skeletal stem cells into bone, cartilage or stromal cells.
"If this is translated into humans, we then have a way to isolate skeletal stem cells and rescue cartilage from wear and tear or aging, repair bones that have nonhealing fractures and renew the bone marrow niche in those who have had it damaged in one way or another," said Irving Weissman, MD, professor of pathology and of developmental biology, who directs the Stanford Institute for Stem Cell Biology and Regenerative Medicine. Weissman, the other senior author of the paper, also holds the Virginia and Daniel K. Ludwig Professorship in Clinical Investigation in Cancer Research.
Reprogramming fat cells
Excerpt from:
Stanford researchers isolate stem cell that gives rise to bones, cartilage in mice